Pomerantz To Be Lead Counsel In Mallinckrodt Investor Suit

By Emlyn Cameron · September 21, 2023, 9:52 PM EDT

Pomerantz LLP has been appointed lead counsel in a suit asserting insolvent drugmaker Mallinckrodt PLC tricked investors into thinking it had recovered from bankruptcy and would make a $200 million payment...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

CONTINENTAL GENERAL INSURANCE COMPANY et al v. MALLINCKRODT PLC et al

Case Number

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

July 07, 2023

Recent Articles By Emlyn

November 04, 2024
Meet The Attys Behind Biotech Co. Gritstone's Ch. 11
August 23, 2024
Clinic Biz Can Tap Additional Ch. 11 Lifeline, Judge Says
June 28, 2024
Cano Health Wins Ch. 11 Plan Confirmation
May 21, 2024
Cano Judge Agrees To OK Ch. 11 Plan Disclosure Statement
May 07, 2024
Meet The Weil Attys Guiding Steward Health's Ch. 11
April 25, 2024
3rd Circ. Lets Mallinckrodt Off Sanofi's Royalty Hook
April 10, 2024
Bankrupt Hospital Co.'s $16M Deal With Ex-Execs OK'd
April 04, 2024
Judge Denies New Official Committee In Talc Ch. 11
March 11, 2024
Judge OKs Eye Care Tech Co.'s $8M DIP Request
March 08, 2024
Sorrento Gets OK For $2M Ch. 11 Funding Infusion, Asset Sale